NFKB1 and allergic asthma: An in vivo assay using a mouse allergic asthma model concluded that andrographolide could reduce allergen-induced inflammation, cellular infiltration in the airway, and airway hyper-responsiveness by inhibiting NF-κB expression in the lung and suppressing the NF-κB expressed in the nucleus of airway epithelial cells [145].